Transparency & Corruption, Procurement
Date
Jun. 30, 2011
Joint PR from the network for sustainable development in public procurement - key demands and messages
The Network for Sustainable Development in Public Procurement on the occasion of the European Commission’s Conference “modernising public procurement” on 30 June 2011 reiterate their ‘five key demands’ for the revision of the procurement Directives.
May. 02, 2011
Europe's public service union: Stop corruption and make lobby more transparent
(Press Communication, 2 May 2011) The European Union recently saw a string of scandals with European Parliamentarians who took money from journalists posing as corporate lobbyists to influence legislation and
Apr. 14, 2011
EPSU response to Commission's consultation on Green Paper on EU public procurement rules
EPSU’s response focuses on public services and sustainable procurement. On public services EPSU stresses that new EU rules should not put pressure on public authorities to use public procurement to provide public services.
Nov. 23, 2010
Public procurement : EPSU demands consistency from the European Commission
The European Federation of Public Service Union (EPSU) together with several other trade unions and civil society organisations (GMB, UNISON, EMF, EFFAT, EFBWW, Solidar, FLO, The Fair Trade Advocacy Office, EFTA, WFTO, FERN and Client Earth) sent a letter to Commissioner Barnier with its initial contribution to the evaluation of the impact and effectiveness of EU procurement legislation and policy.
Nov. 23, 2010
EPSU and Civil Society letter to Commissioner Barnier on Procurement
The letter sent by EPSU together with other trade unions and civil society organisation on Public procurement, as well as the report on the Evaluation of the impact and effectiveness of EU procurement legislation and policy.
Aug. 16, 2010
New Survey details influence of Big Pharma on patient and consumer organizations
(16 August 2010) An independent NGO Health Action International (HAI) Europe published research based on a survey on levels of financial disclosure and transparency among patient and consumer organisations at